CST is actively seeking funding, IMO.
They edited the statement on their website about their new study to change 2nd Qtr to 3rd Qtr. There would be no reason to do this if the site was just a placeholder or prototype or temporary site. CST is clearly LIVE and CURRENT and SEEKING INVESTORS. Apparently not US Investors, but I don't think the Australian Officers made a lot of friends in the US when they took over Radient Pharmaceuticals and promptly made it disappear.
Radient Pharmaceuticals crashed and burned. CST is the Phoenix to rise from the ashes of Radient Pharmaceuticals. RXPC shares did not survive the fire.
I think too much is being made of the name "onko-sure." I don't see why CST would care if others want to use that name. I think CST is smart in not using the name "onko-sure" because (a) they are marketing the development and sale of a NEW device, not the same old DR70 test, and (b) the investing world and the medical world associate "onko-sure" with a failed product.
So, let others use the name onko-sure -- I'm quite sure that CST doesn't care.
News 
Market Data 
Discover 
